Suchergebnisse - Finite element modelling in high-performance computing

  1. 1
  2. 2
  3. 3
  4. 4

    Weitere Verfasser: University/Department: Universitat Politècnica de Catalunya. Escola Tècnica Superior d'Enginyers de Camins, Canals i Ports de Barcelona

    Thesis Advisors: Chiumenti, M. (Michele), Badia, Santiago

    Quelle: TDX (Tesis Doctorals en Xarxa)

    Dateibeschreibung: application/pdf

  5. 5

    Weitere Verfasser: University/Department: Universitat Politècnica de Catalunya. Departament d'Arquitectura de Computadors

    Thesis Advisors: Cela Espín, José M. (José María), Puente Álvarez, Josep de la

    Quelle: TDX (Tesis Doctorals en Xarxa)

    Dateibeschreibung: application/pdf

  6. 6
  7. 7

    Autoren: Oks, David

    Weitere Verfasser: University/Department: Universitat Politècnica de Catalunya. Facultat de Matemàtiques i Estadística

    Thesis Advisors: Samaniego, Cristóbal, Houzeaux, Guillaume, Vázquez, Mariano

    Quelle: TDX (Tesis Doctorals en Xarxa)

    Dateibeschreibung: application/pdf

  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Quelle: Philosophical Transactions: Mathematical, Physical and Engineering Sciences, 2009 May . 367(1895), 1951-1969.

  13. 13

    Quelle: Evans, L M, Margetts, L, Casalegno, V, Lever, L, Bushell, J, Lowe, T, Wallwork, A, Young, P, Lindemann, A, Schmidt, M & Mummery, P 2015, 'Transient Thermal Finite Element Analysis of CFC-Cu ITER Monoblock Using X-ray Tomography Data', Fusion Engineering and Design, vol. 100, pp. 100-111. https://doi.org/10.1016/j.fusengdes.2015.04.048

  14. 14
  15. 15

    Schlagwörter: ψ–Hamzah model, fractional calculus, fractal dynamics, fractional derivative, Caputo derivative, Grünwald–Letnikov approximation, Mittag–Leffler function, complex integral, stochastic modelling, fractional pharmacokinetics, pharmacodynamics, PK/PD modelling, cell regeneration index, CRI, immune modulation, nanomedicine, liposomal drug delivery, liposomal formulation, DSPC, DSPE-PEG2000, cholesterol stabilisation, Vit-E TPGS, mannitol isotonicity, nanoparticle stability, liposomal encapsulation, oral sustained release, HPMC K15M, povidone K30, magnesium stearate, colloidal silica, trehalose stabilisation, mannitol cryoprotection, bioreactor optimisation, protein folding, antigen presentation, vaccine formulation, anti-cancer therapy, multidrug resistance, antimicrobial resistance, resistant pneumonia, sepsis resistant strains, HLA diversity, Toll-like receptor signalling, innate immunity, adaptive immunity, immune kinetics, fractional immunology, immune homeostasis, cytokine regulation, T-cell activation, B-cell response, dendritic cell signalling, macrophage regulation, NK cell activation, in vitro validation, in vivo validation, clinical phase II, clinical phase III, field validation, real-world validation, resistant paediatric pneumonia, global health strategy, WHO safety standards, clinical efficacy, adverse event minimisation, fractional pharmacology, fractal pharmacology, fractal kinetics, non-linear dynamics, memory effects, long-range dependency, herst exponent modelling, fractional noise, Gaussian perturbations, stochastic resonance, bioinformatics, systems biology, computational biology, mathematical medicine, fractional immunotherapy, regenerative medicine, tissue regeneration, CRISPR integration, genetic mutations, drug resistance mutations, oncogenic signalling, cancer immunotherapy, targeted therapy, biomarker integration, omics modelling, proteomics, transcriptomics, metabolomics, nanocarrier stability, liposome stability, particle size distribution, DLS analysis, FTIR monitoring, spectral resolution, nanoparticle characterisation, ISO cleanroom standards, ISO 14644-1, HEPA H14, laminar flow, bioreactor pH control, lyophilisation, long-term storage, cold chain stability, thermal shock resistance, bioactivity stability, complex stability model, long-term modelling, five-year stability prediction, PK/PD simulations, multi-scale modelling, cellular uptake, receptor binding, ligand-receptor kinetics, antibody responses, epitope recognition, vaccine adjuvantation, adjuvant optimisation, PEGylation, immune evasion, complement system regulation, oxidative stress reduction, antioxidant therapy, TPGS antioxidant role, mannose receptor targeting, targeted nanomedicine, site-specific delivery, pulmonary drug delivery, systemic drug delivery, intravenous administration, oral administration, fractional release kinetics, slow release dynamics, bioavailability optimisation, metabolic stability, enzymatic degradation, protease resistance, metalloprotease inhibition, EDTA stabilisation, structural modelling, computational pharmacology, Python simulations, high performance computing, numerical integration, fractional differential equations, ODE comparison, stochastic simulations, multi-scenario validation, one trillion scenario modelling, ultra-large simulations, scalability, reproducibility, Monte Carlo validation, numerical robustness, sensitivity analysis, parameter optimisation, machine learning integration, AI-driven modelling, deep learning pharmacology, predictive modelling, personalised medicine, precision medicine, adaptive therapy, dynamic therapy adjustment, long-term monitoring, field trial validation, epidemiological modelling, outbreak control, pandemic preparedness, resistant pathogen strategy, antimicrobial stewardship, paediatric infectious diseases, cancer modelling, solid tumour modelling, leukaemia modelling, lung cancer modelling, breast cancer modelling, colon cancer modelling, glioblastoma modelling, pancreatic cancer therapy, resistant cancer phenotypes, immuno-oncology, checkpoint inhibitors, PD-1 modulation, CTLA-4 blockade, CAR-T cell synergy, mRNA vaccine integration, DNA vaccine modelling, peptide vaccine optimisation, antigen epitope prediction, vaccine design, vaccine delivery, nanovaccine development, next-generation vaccines, fractional vaccine kinetics, integrative immunotherapy, combinatorial therapy, fractional chemotherapy, radiation synergy modelling, clinical data harmonisation, international trials, intellectual property rights, IPR, patent protection, legal framework, WHO policy integration, UN health policy, global database standardisation, biomathematics, medical mathematics, health informatics, translational research, experimental medicine, laboratory medicine, pharmacological validation, toxicological evaluation, regulatory science, EMA submission, FDA submission, global regulatory harmonisation, Good Manufacturing Practice, GMP, GxP compliance, ISO standards, reproducibility in science, field reproducibility, laboratory reproducibility, open science standards, peer-reviewed validation, Nature Medicine standards, The Lancet standards, NEJM publication potential, clinical translation, patient safety, long-term safety monitoring, bioethical standards, biomedical innovation, interdisciplinary integration, multi-scale biophysics, nanobiophysics, molecular modelling, structural bioinformatics, thermodynamics of drug delivery, entropy-driven release, free energy landscape, molecular stability, fractional entropy, thermodynamic modelling, entropy minimisation, noise control, robustness of therapy, adaptive immune response, memory cell generation, B-cell affinity maturation, T-cell receptor diversity, clonal expansion, cross-reactivity, pathogen mutation modelling, stochastic mutation rates, mutational landscape, evolutionary dynamics, evolutionary game theory, resistant strain modelling, ecological resilience, host-pathogen interactions, population dynamics, epidemiological resilience, fractional epidemiology, fractional SEIR model, fractional SIR model, vaccine coverage optimisation, herd immunity modelling, transmission blocking, pathogen eradication, health economics, cost-effectiveness modelling, pharmacoeconomics, global health financing, research prioritisation, innovation strategy, translational framework, clinical decision support, health AI systems, advanced Python simulation, code optimisation, fractional coding, fractal coding, big data pharmacology, ultra-scale simulations, trillion-scenario computation, HPC pharmacology, exascale computing, quantum pharmacology modelling, quantum biological dynamics, wavefunction pharmacology, energy landscape modelling, dynamic systems optimisation, neural network pharmacology, reinforcement learning in medicine, generative models in pharmacology, bio-optimisation, fractional modelling platform, computational reproducibility, code verification, algorithmic robustness, modelling ethics, computational transparency, interdisciplinary framework, scientific reproducibility, theoretical biomedicine, applied pharmacology, clinical translation pipeline, personalised vaccine modelling, integrative oncology, fractional regenerative therapy, predictive regenerative medicine, adaptive immune modelling, deterministic chaos, controlled chaos therapy, stochastic fractional therapy, hybrid mathematical models, deterministic-stochastic hybridisation, fractional hybrid models, multi-compartment pharmacokinetics, whole-body modelling, virtual patient modelling, digital twin medicine, bio-simulation, computational immunology, immunodynamics, biomolecular systems, cell signalling pathways, MAPK signalling, NF-κB signalling, PI3K/AKT pathway, mTOR pathway, apoptosis regulation, autophagy dynamics, necroptosis modelling, ferroptosis modelling, immune cell exhaustion, T-cell exhaustion, immune checkpoint dynamics, immune evasion modelling, multi-drug combinations, synergistic therapy, dose-response modelling, Hill function modelling, fractional Hill equation, toxicity minimisation, therapeutic window optimisation, precision dosing, dosing algorithms, dose-finding studies, Bayesian adaptive trials, hierarchical modelling, multi-centre trials, data harmonisation, reproducibility studies, computational-experimental synergy, field-laboratory integration, modelling-experiment feedback, next-generation drug design, rational drug design, in silico pharmacology, computational drug discovery, structural drug design, AI in drug design, biomimetic design, nanostructure optimisation, bioengineering frameworks, synthetic biology integration, biotechnological innovation, cell-based therapies, stem cell modelling, induced pluripotent stem cells, mesenchymal stem cells, regenerative scaffolds, nanoscaffolds, tissue engineering, biofabrication, bio-3D printing, integrative bioengineering, translational nanomedicine, nano-immunotherapy, virus-like particle vaccines, nanoparticle adjuvants, nanoemulsion delivery, hybrid nanoparticle systems, biomaterials in medicine, biodegradable polymers, PEGylated systems, controlled release systems, advanced delivery vectors, supramolecular assemblies, self-assembly modelling, nano-scale thermodynamics, Brownian motion modelling, diffusion modelling, anomalous diffusion, sub-diffusion modelling, super-diffusion modelling, fractional diffusion equations, Lévy flights in biology, random walk immunology, stochastic fractional calculus, fractional Laplacian, advanced numerical methods, adaptive time stepping, implicit-explicit solvers, stiff equation solvers, spectral methods, Chebyshev methods, finite element modelling, finite difference schemes, boundary conditions, absorbing boundaries, reflective boundaries, physiological constraints, validation with real data, clinical dataset modelling, personalised parameter estimation, parameter uncertainty quantification, posterior distribution modelling, Bayesian pharmacology, statistical inference in medicine, multi-level modelling, hierarchical Bayesian models, frequentist vs Bayesian approaches, maximum likelihood estimation, robust statistical inference, statistical learning, uncertainty minimisation, variance reduction, sensitivity testing, robustness testing, predictive confidence intervals, uncertainty quantification, clinical significance, effect size, reproducibility metrics, global reproducibility standards, international harmonisation, and translational adoption

  16. 16
  17. 17
  18. 18
  19. 19
  20. 20